Responsibly using and disclosing de-identified data under the HIPAA Privacy Rule

A session at Strata Rx

Wednesday 17th October, 2012

4:05pm to 4:45pm (PST)

Organizations, both private and public sector are sitting on large amounts of valuable health data – whether they are researchers, pharmaceutical companies, healthcare providers, health IT developers, insurers, or claims processors. The value in this data can be unlocked to improve efficiencies and to create new business opportunities if it can be used and disclosed. The HIPAA Privacy Rule provides mechanisms for using and disclosing health data responsibly without the need for patient authorization. These mechanisms center around the HIPAA de-identification standards. In this tutorial we will describe the de-identification standards in HIPAA, how to interpret them in a practical manner, and how to apply the HIPAA de-identification standards to de-identify health data in a defensible way.

Attendees will:

  • Get an introduction to the general concepts around the de-identification of health information
  • Understand the HIPAA Privacy Rule de-identification standards and how they can be operationalized
  • Learn through examples how data sets can be de-identified and disclosed, and how they can still retain significant utility for sophisticated analytics

About the speakers

This person is speaking at this event.
Khaled El Emam

Khaled El Emam is an Associate Professor at the University of Ottawa, Faculty of Medicine, and a Canada Research Chair in Electronic Health Information. bio from Twitter

This person is speaking at this event.
David Houlding

Healthcare Privacy & Security Lead Architect, Intel

Sign in to add slides, notes or videos to this session

Tell your friends!


Time 4:05pm4:45pm PST

Date Wed 17th October 2012

Short URL


View the schedule


See something wrong?

Report an issue with this session